but I don't want to hear about anything that is so

Quote:

---

but I don't want to hear about anything that is so speculative, so far off, and so unlikely to ever put money in the bank.

---

Very little speculation with what is known about CCR5, inflammation and stroke. Unless Cytodyn has a shareholder vote to turn the company into a charity it's highly likely that indication will generate good revenue. How far off depends on if we can get to revenue with COVID before leronlimab becomes irrelevant.